Abstract
The goal of antihypertensive treatment, in addition to lowering blood pressure, is to reduce the risk of cardiovascular events. Until recently, however, only conventional treatment with diuretics and β-blockers had been studied in terms of cardiovascular end points. In this article, Dr Yeun reviews the results of recent trials comparing these agents with other classes of antihypertensive drugs. She examines the confounding elements in the trials, provides an interpretation of study results, and suggests a practical approach to initial treatment of uncomplicated hypertension.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 39-54 |
| Number of pages | 16 |
| Journal | Postgraduate Medicine |
| Volume | 110 |
| Issue number | 5 |
| State | Published - 2001 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Initial antihypertensive therapy : What are the current drugs of choice? / Yeun, Jane Y.
In: Postgraduate Medicine, Vol. 110, No. 5, 2001, p. 39-54.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Initial antihypertensive therapy
T2 - What are the current drugs of choice?
AU - Yeun, Jane Y
PY - 2001
Y1 - 2001
N2 - The goal of antihypertensive treatment, in addition to lowering blood pressure, is to reduce the risk of cardiovascular events. Until recently, however, only conventional treatment with diuretics and β-blockers had been studied in terms of cardiovascular end points. In this article, Dr Yeun reviews the results of recent trials comparing these agents with other classes of antihypertensive drugs. She examines the confounding elements in the trials, provides an interpretation of study results, and suggests a practical approach to initial treatment of uncomplicated hypertension.
AB - The goal of antihypertensive treatment, in addition to lowering blood pressure, is to reduce the risk of cardiovascular events. Until recently, however, only conventional treatment with diuretics and β-blockers had been studied in terms of cardiovascular end points. In this article, Dr Yeun reviews the results of recent trials comparing these agents with other classes of antihypertensive drugs. She examines the confounding elements in the trials, provides an interpretation of study results, and suggests a practical approach to initial treatment of uncomplicated hypertension.
UR - http://www.scopus.com/inward/record.url?scp=0035171189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035171189&partnerID=8YFLogxK
M3 - Article
C2 - 11727652
AN - SCOPUS:0035171189
VL - 110
SP - 39
EP - 54
JO - Postgraduate Medicine
JF - Postgraduate Medicine
SN - 0032-5481
IS - 5
ER -